Breast cancer survivors accurately reported key treatment and prognostic characteristics

被引:65
作者
Maunsell, E [1 ]
Drolet, M
Ouhoummane, N
Robert, J
机构
[1] Ctr Hosp Affilie Univ Quebec, Ctr Rech, Unite Rech Sante Populat, Quebec City, PQ, Canada
[2] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada
[3] Hop St Sacrement, Ctr Maladies Sein Deschenes Fabia, St Foy, PQ G1S 4L8, Canada
基金
加拿大健康研究院;
关键词
validity; agreement; breast cancer; medical records; self-report; questionnaire; treatments; prognosis; quality of life; survivors;
D O I
10.1016/j.jclinepi.2004.09.005
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background and Objective: Medical records are considered the gold standard for information on cancer treatments and prognosis. We compared survivor self-report and medical records for agreement on key treatment and prognostic characteristics. Study Design and Setting: A population-based study was conducted in Quebec assessing work experience among breast cancer survivors aged < 60 years at diagnosis. Data came from a single telephone interview 3.4 +/- 0.2 years after diagnosis. Medical record data were available for 103 out of 646 participants. Results: Agreement of self-report with medical record data was very high for treatments (breast surgery, type of mastectomy, axillary dissection, radiotherapy, chemotherapy, hormone therapy, reconstruction, bone marrow transplantation). Kappa values varied from 0.89 for axillary dissection to 1.00 for breast surgery. Kappa values for number of invaded nodes (0, 1-3, >= 4, unknown) was slightly lower (0.85) but was still excellent. When accepting answers +/- I month of the medical record date, >= 89% of women correctly reported different treatment dates. Conclusion: These results provide evidence of the validity of summary treatment and prognostic data reported by breast cancer survivors 3 years after diagnosis. Survivors can likely accurately describe the treatment trajectory and key prognostic information when medical record review is unfeasible. These findings may need replication among older women. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:364 / 369
页数:6
相关论文
共 11 条
[1]   Cognitive function in breast cancer patients receiving adjuvant chemotherapy [J].
Brezden, CB ;
Phillips, KA ;
Abdolell, M ;
Bunston, T ;
Tannock, IF .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) :2695-2701
[2]   Comparison of self-reported initial treatment with medical records: Results from the prostate cancer outcomes study [J].
Clegg, LX ;
Potosky, AL ;
Harlan, LC ;
Hankey, BF ;
Hoffman, RM ;
Stanford, JL ;
Hamilton, AS .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 154 (06) :582-587
[3]  
Foddy W., 1993, Constructing Questions for Interviews and Questionnaires
[4]   Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect? [J].
Ganz, PA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (03) :182-183
[5]   MEASUREMENT OF OBSERVER AGREEMENT FOR CATEGORICAL DATA [J].
LANDIS, JR ;
KOCH, GG .
BIOMETRICS, 1977, 33 (01) :159-174
[6]  
MAUNSELL E, 1996, FDN QUEBECOISE CANC
[7]  
MAUNSELL E, 1995, CANADIAN BREAST CANC
[8]   Epidemiology deserves better questionnaires [J].
Olsen, J .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1998, 27 (06) :935-935
[9]  
Turner R. J., 1995, Measuring stress. A guide for health and social sciences, P29
[10]   Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy [J].
van Dam, FSAM ;
Schagen, SB ;
Muller, MJ ;
Boogerd, W ;
von der Wall, E ;
Fortuyn, MED ;
Rodenhuis, S .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (03) :210-218